A multicenter RCT [68] compared the effects of transient intensive insulin therapy (continuous subcutaneous insulin infusion [CSII] or multiple daily injections [MDI]) vs. oral antidiabetic agents on β-cell function and diabetes remission. This evidence concerns the gene INS and diabetes mellitus.